0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable for Cosmetic Surgery Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-27V496
Home | Market Reports | Beauty & Fitness| Cosmetic Procedures| Cosmetic Surgery
Global Injectable for Cosmetic Surgery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Injectable for Cosmetic Surgery Market Research Report 2024

Code: QYRE-Auto-27V496
Report
January 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Injectable for Cosmetic Surgery Market Size

The global Injectable for Cosmetic Surgery market was valued at US$ 45840 million in 2023 and is anticipated to reach US$ 173000 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.

Injectable for Cosmetic Surgery Market

Injectable for Cosmetic Surgery Market

Cosmetic surgery is a process that enhances or alters a portion of an individual’s body, or, face through incision. Cosmetic surgeries include reconstruction or reshaping of body parts, altering facial structure (maxillofacial), altering structure of jaw (craniofacial), etc. People from urban areas constitute the largest patient base for cosmetic surgeries due to increased aesthetic appeal.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable for Cosmetic Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable for Cosmetic Surgery.

Report Scope

The Injectable for Cosmetic Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable for Cosmetic Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable for Cosmetic Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Injectable for Cosmetic Surgery Market Report

Report Metric Details
Report Name Injectable for Cosmetic Surgery Market
Accounted market size in 2023 US$ 45840 million
Forecasted market size in 2030 US$ 173000 million
CAGR 20.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Botulinum Toxin
  • Soft Tissue Fillers
  • Dermal Fillers
  • Others
Segment by Application
  • Hospitals
  • Dermatology Clinics
  • Beauty Centers
  • Othes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological, Q.O.Fill (JW Pharmaceutical), Teoxane, Sinclair, Suneva Medical, CG Bio, SciVision Biotech, Prollenium, Matex-Lab, Jingjia Medical, Genoss, Bohus BioTech, Caregen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Injectable for Cosmetic Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Injectable for Cosmetic Surgery Market growing?

Ans: The Injectable for Cosmetic Surgery Market witnessing a CAGR of 20.6% during the forecast period 2024-2030.

What is the Injectable for Cosmetic Surgery Market size in 2030?

Ans: The Injectable for Cosmetic Surgery Market size in 2030 will be US$ 173000 million.

Who are the main players in the Injectable for Cosmetic Surgery Market report?

Ans: The main players in the Injectable for Cosmetic Surgery Market are AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological, Q.O.Fill (JW Pharmaceutical), Teoxane, Sinclair, Suneva Medical, CG Bio, SciVision Biotech, Prollenium, Matex-Lab, Jingjia Medical, Genoss, Bohus BioTech, Caregen

What are the Application segmentation covered in the Injectable for Cosmetic Surgery Market report?

Ans: The Applications covered in the Injectable for Cosmetic Surgery Market report are Hospitals, Dermatology Clinics, Beauty Centers, Othes

What are the Type segmentation covered in the Injectable for Cosmetic Surgery Market report?

Ans: The Types covered in the Injectable for Cosmetic Surgery Market report are Botulinum Toxin, Soft Tissue Fillers, Dermal Fillers, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable for Cosmetic Surgery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Botulinum Toxin
1.2.3 Soft Tissue Fillers
1.2.4 Dermal Fillers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable for Cosmetic Surgery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Beauty Centers
1.3.5 Othes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable for Cosmetic Surgery Market Perspective (2019-2030)
2.2 Injectable for Cosmetic Surgery Growth Trends by Region
2.2.1 Global Injectable for Cosmetic Surgery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable for Cosmetic Surgery Historic Market Size by Region (2019-2024)
2.2.3 Injectable for Cosmetic Surgery Forecasted Market Size by Region (2025-2030)
2.3 Injectable for Cosmetic Surgery Market Dynamics
2.3.1 Injectable for Cosmetic Surgery Industry Trends
2.3.2 Injectable for Cosmetic Surgery Market Drivers
2.3.3 Injectable for Cosmetic Surgery Market Challenges
2.3.4 Injectable for Cosmetic Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable for Cosmetic Surgery Players by Revenue
3.1.1 Global Top Injectable for Cosmetic Surgery Players by Revenue (2019-2024)
3.1.2 Global Injectable for Cosmetic Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Injectable for Cosmetic Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable for Cosmetic Surgery Revenue
3.4 Global Injectable for Cosmetic Surgery Market Concentration Ratio
3.4.1 Global Injectable for Cosmetic Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable for Cosmetic Surgery Revenue in 2023
3.5 Injectable for Cosmetic Surgery Key Players Head office and Area Served
3.6 Key Players Injectable for Cosmetic Surgery Product Solution and Service
3.7 Date of Enter into Injectable for Cosmetic Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable for Cosmetic Surgery Breakdown Data by Type
4.1 Global Injectable for Cosmetic Surgery Historic Market Size by Type (2019-2024)
4.2 Global Injectable for Cosmetic Surgery Forecasted Market Size by Type (2025-2030)
5 Injectable for Cosmetic Surgery Breakdown Data by Application
5.1 Global Injectable for Cosmetic Surgery Historic Market Size by Application (2019-2024)
5.2 Global Injectable for Cosmetic Surgery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable for Cosmetic Surgery Market Size (2019-2030)
6.2 North America Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
6.4 North America Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable for Cosmetic Surgery Market Size (2019-2030)
7.2 Europe Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
7.4 Europe Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable for Cosmetic Surgery Market Size (2019-2030)
8.2 Asia-Pacific Injectable for Cosmetic Surgery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable for Cosmetic Surgery Market Size (2019-2030)
9.2 Latin America Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
9.4 Latin America Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable for Cosmetic Surgery Market Size (2019-2030)
10.2 Middle East & Africa Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Injectable for Cosmetic Surgery Introduction
11.1.4 AbbVie Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Galderma
11.2.1 Galderma Company Detail
11.2.2 Galderma Business Overview
11.2.3 Galderma Injectable for Cosmetic Surgery Introduction
11.2.4 Galderma Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.2.5 Galderma Recent Development
11.3 LG Life Sciences
11.3.1 LG Life Sciences Company Detail
11.3.2 LG Life Sciences Business Overview
11.3.3 LG Life Sciences Injectable for Cosmetic Surgery Introduction
11.3.4 LG Life Sciences Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.3.5 LG Life Sciences Recent Development
11.4 Merz
11.4.1 Merz Company Detail
11.4.2 Merz Business Overview
11.4.3 Merz Injectable for Cosmetic Surgery Introduction
11.4.4 Merz Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.4.5 Merz Recent Development
11.5 Medytox
11.5.1 Medytox Company Detail
11.5.2 Medytox Business Overview
11.5.3 Medytox Injectable for Cosmetic Surgery Introduction
11.5.4 Medytox Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.5.5 Medytox Recent Development
11.6 HUGEL
11.6.1 HUGEL Company Detail
11.6.2 HUGEL Business Overview
11.6.3 HUGEL Injectable for Cosmetic Surgery Introduction
11.6.4 HUGEL Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.6.5 HUGEL Recent Development
11.7 Croma-Pharma
11.7.1 Croma-Pharma Company Detail
11.7.2 Croma-Pharma Business Overview
11.7.3 Croma-Pharma Injectable for Cosmetic Surgery Introduction
11.7.4 Croma-Pharma Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.7.5 Croma-Pharma Recent Development
11.8 Beijing IMEIK
11.8.1 Beijing IMEIK Company Detail
11.8.2 Beijing IMEIK Business Overview
11.8.3 Beijing IMEIK Injectable for Cosmetic Surgery Introduction
11.8.4 Beijing IMEIK Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.8.5 Beijing IMEIK Recent Development
11.9 Bloomage Bio
11.9.1 Bloomage Bio Company Detail
11.9.2 Bloomage Bio Business Overview
11.9.3 Bloomage Bio Injectable for Cosmetic Surgery Introduction
11.9.4 Bloomage Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.9.5 Bloomage Bio Recent Development
11.10 Elravie (Humedix)
11.10.1 Elravie (Humedix) Company Detail
11.10.2 Elravie (Humedix) Business Overview
11.10.3 Elravie (Humedix) Injectable for Cosmetic Surgery Introduction
11.10.4 Elravie (Humedix) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.10.5 Elravie (Humedix) Recent Development
11.11 Cleviel (Pharma Research Products)
11.11.1 Cleviel (Pharma Research Products) Company Detail
11.11.2 Cleviel (Pharma Research Products) Business Overview
11.11.3 Cleviel (Pharma Research Products) Injectable for Cosmetic Surgery Introduction
11.11.4 Cleviel (Pharma Research Products) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.11.5 Cleviel (Pharma Research Products) Recent Development
11.12 Haohai Biological
11.12.1 Haohai Biological Company Detail
11.12.2 Haohai Biological Business Overview
11.12.3 Haohai Biological Injectable for Cosmetic Surgery Introduction
11.12.4 Haohai Biological Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.12.5 Haohai Biological Recent Development
11.13 Q.O.Fill (JW Pharmaceutical)
11.13.1 Q.O.Fill (JW Pharmaceutical) Company Detail
11.13.2 Q.O.Fill (JW Pharmaceutical) Business Overview
11.13.3 Q.O.Fill (JW Pharmaceutical) Injectable for Cosmetic Surgery Introduction
11.13.4 Q.O.Fill (JW Pharmaceutical) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.13.5 Q.O.Fill (JW Pharmaceutical) Recent Development
11.14 Teoxane
11.14.1 Teoxane Company Detail
11.14.2 Teoxane Business Overview
11.14.3 Teoxane Injectable for Cosmetic Surgery Introduction
11.14.4 Teoxane Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.14.5 Teoxane Recent Development
11.15 Sinclair
11.15.1 Sinclair Company Detail
11.15.2 Sinclair Business Overview
11.15.3 Sinclair Injectable for Cosmetic Surgery Introduction
11.15.4 Sinclair Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.15.5 Sinclair Recent Development
11.16 Suneva Medical
11.16.1 Suneva Medical Company Detail
11.16.2 Suneva Medical Business Overview
11.16.3 Suneva Medical Injectable for Cosmetic Surgery Introduction
11.16.4 Suneva Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.16.5 Suneva Medical Recent Development
11.17 CG Bio
11.17.1 CG Bio Company Detail
11.17.2 CG Bio Business Overview
11.17.3 CG Bio Injectable for Cosmetic Surgery Introduction
11.17.4 CG Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.17.5 CG Bio Recent Development
11.18 SciVision Biotech
11.18.1 SciVision Biotech Company Detail
11.18.2 SciVision Biotech Business Overview
11.18.3 SciVision Biotech Injectable for Cosmetic Surgery Introduction
11.18.4 SciVision Biotech Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.18.5 SciVision Biotech Recent Development
11.19 Prollenium
11.19.1 Prollenium Company Detail
11.19.2 Prollenium Business Overview
11.19.3 Prollenium Injectable for Cosmetic Surgery Introduction
11.19.4 Prollenium Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.19.5 Prollenium Recent Development
11.20 Matex-Lab
11.20.1 Matex-Lab Company Detail
11.20.2 Matex-Lab Business Overview
11.20.3 Matex-Lab Injectable for Cosmetic Surgery Introduction
11.20.4 Matex-Lab Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.20.5 Matex-Lab Recent Development
11.21 Jingjia Medical
11.21.1 Jingjia Medical Company Detail
11.21.2 Jingjia Medical Business Overview
11.21.3 Jingjia Medical Injectable for Cosmetic Surgery Introduction
11.21.4 Jingjia Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.21.5 Jingjia Medical Recent Development
11.22 Genoss
11.22.1 Genoss Company Detail
11.22.2 Genoss Business Overview
11.22.3 Genoss Injectable for Cosmetic Surgery Introduction
11.22.4 Genoss Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.22.5 Genoss Recent Development
11.23 Bohus BioTech
11.23.1 Bohus BioTech Company Detail
11.23.2 Bohus BioTech Business Overview
11.23.3 Bohus BioTech Injectable for Cosmetic Surgery Introduction
11.23.4 Bohus BioTech Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.23.5 Bohus BioTech Recent Development
11.24 Caregen
11.24.1 Caregen Company Detail
11.24.2 Caregen Business Overview
11.24.3 Caregen Injectable for Cosmetic Surgery Introduction
11.24.4 Caregen Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.24.5 Caregen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Injectable for Cosmetic Surgery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Botulinum Toxin
    Table 3. Key Players of Soft Tissue Fillers
    Table 4. Key Players of Dermal Fillers
    Table 5. Key Players of Others
    Table 6. Global Injectable for Cosmetic Surgery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Injectable for Cosmetic Surgery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Injectable for Cosmetic Surgery Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Injectable for Cosmetic Surgery Market Share by Region (2019-2024)
    Table 10. Global Injectable for Cosmetic Surgery Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Injectable for Cosmetic Surgery Market Share by Region (2025-2030)
    Table 12. Injectable for Cosmetic Surgery Market Trends
    Table 13. Injectable for Cosmetic Surgery Market Drivers
    Table 14. Injectable for Cosmetic Surgery Market Challenges
    Table 15. Injectable for Cosmetic Surgery Market Restraints
    Table 16. Global Injectable for Cosmetic Surgery Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Injectable for Cosmetic Surgery Market Share by Players (2019-2024)
    Table 18. Global Top Injectable for Cosmetic Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable for Cosmetic Surgery as of 2023)
    Table 19. Ranking of Global Top Injectable for Cosmetic Surgery Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Injectable for Cosmetic Surgery Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Injectable for Cosmetic Surgery Product Solution and Service
    Table 23. Date of Enter into Injectable for Cosmetic Surgery Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Injectable for Cosmetic Surgery Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Injectable for Cosmetic Surgery Revenue Market Share by Type (2019-2024)
    Table 27. Global Injectable for Cosmetic Surgery Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Injectable for Cosmetic Surgery Revenue Market Share by Type (2025-2030)
    Table 29. Global Injectable for Cosmetic Surgery Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Injectable for Cosmetic Surgery Revenue Market Share by Application (2019-2024)
    Table 31. Global Injectable for Cosmetic Surgery Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Injectable for Cosmetic Surgery Revenue Market Share by Application (2025-2030)
    Table 33. North America Injectable for Cosmetic Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Injectable for Cosmetic Surgery Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Injectable for Cosmetic Surgery Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Injectable for Cosmetic Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Injectable for Cosmetic Surgery Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Injectable for Cosmetic Surgery Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Injectable for Cosmetic Surgery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Injectable for Cosmetic Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Injectable for Cosmetic Surgery Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Injectable for Cosmetic Surgery Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Injectable for Cosmetic Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2025-2030) & (US$ Million)
    Table 48. AbbVie Company Detail
    Table 49. AbbVie Business Overview
    Table 50. AbbVie Injectable for Cosmetic Surgery Product
    Table 51. AbbVie Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 52. AbbVie Recent Development
    Table 53. Galderma Company Detail
    Table 54. Galderma Business Overview
    Table 55. Galderma Injectable for Cosmetic Surgery Product
    Table 56. Galderma Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 57. Galderma Recent Development
    Table 58. LG Life Sciences Company Detail
    Table 59. LG Life Sciences Business Overview
    Table 60. LG Life Sciences Injectable for Cosmetic Surgery Product
    Table 61. LG Life Sciences Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 62. LG Life Sciences Recent Development
    Table 63. Merz Company Detail
    Table 64. Merz Business Overview
    Table 65. Merz Injectable for Cosmetic Surgery Product
    Table 66. Merz Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 67. Merz Recent Development
    Table 68. Medytox Company Detail
    Table 69. Medytox Business Overview
    Table 70. Medytox Injectable for Cosmetic Surgery Product
    Table 71. Medytox Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 72. Medytox Recent Development
    Table 73. HUGEL Company Detail
    Table 74. HUGEL Business Overview
    Table 75. HUGEL Injectable for Cosmetic Surgery Product
    Table 76. HUGEL Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 77. HUGEL Recent Development
    Table 78. Croma-Pharma Company Detail
    Table 79. Croma-Pharma Business Overview
    Table 80. Croma-Pharma Injectable for Cosmetic Surgery Product
    Table 81. Croma-Pharma Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 82. Croma-Pharma Recent Development
    Table 83. Beijing IMEIK Company Detail
    Table 84. Beijing IMEIK Business Overview
    Table 85. Beijing IMEIK Injectable for Cosmetic Surgery Product
    Table 86. Beijing IMEIK Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 87. Beijing IMEIK Recent Development
    Table 88. Bloomage Bio Company Detail
    Table 89. Bloomage Bio Business Overview
    Table 90. Bloomage Bio Injectable for Cosmetic Surgery Product
    Table 91. Bloomage Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 92. Bloomage Bio Recent Development
    Table 93. Elravie (Humedix) Company Detail
    Table 94. Elravie (Humedix) Business Overview
    Table 95. Elravie (Humedix) Injectable for Cosmetic Surgery Product
    Table 96. Elravie (Humedix) Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 97. Elravie (Humedix) Recent Development
    Table 98. Cleviel (Pharma Research Products) Company Detail
    Table 99. Cleviel (Pharma Research Products) Business Overview
    Table 100. Cleviel (Pharma Research Products) Injectable for Cosmetic Surgery Product
    Table 101. Cleviel (Pharma Research Products) Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 102. Cleviel (Pharma Research Products) Recent Development
    Table 103. Haohai Biological Company Detail
    Table 104. Haohai Biological Business Overview
    Table 105. Haohai Biological Injectable for Cosmetic Surgery Product
    Table 106. Haohai Biological Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 107. Haohai Biological Recent Development
    Table 108. Q.O.Fill (JW Pharmaceutical) Company Detail
    Table 109. Q.O.Fill (JW Pharmaceutical) Business Overview
    Table 110. Q.O.Fill (JW Pharmaceutical) Injectable for Cosmetic Surgery Product
    Table 111. Q.O.Fill (JW Pharmaceutical) Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 112. Q.O.Fill (JW Pharmaceutical) Recent Development
    Table 113. Teoxane Company Detail
    Table 114. Teoxane Business Overview
    Table 115. Teoxane Injectable for Cosmetic Surgery Product
    Table 116. Teoxane Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 117. Teoxane Recent Development
    Table 118. Sinclair Company Detail
    Table 119. Sinclair Business Overview
    Table 120. Sinclair Injectable for Cosmetic Surgery Product
    Table 121. Sinclair Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 122. Sinclair Recent Development
    Table 123. Suneva Medical Company Detail
    Table 124. Suneva Medical Business Overview
    Table 125. Suneva Medical Injectable for Cosmetic Surgery Product
    Table 126. Suneva Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 127. Suneva Medical Recent Development
    Table 128. CG Bio Company Detail
    Table 129. CG Bio Business Overview
    Table 130. CG Bio Injectable for Cosmetic Surgery Product
    Table 131. CG Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 132. CG Bio Recent Development
    Table 133. SciVision Biotech Company Detail
    Table 134. SciVision Biotech Business Overview
    Table 135. SciVision Biotech Injectable for Cosmetic Surgery Product
    Table 136. SciVision Biotech Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 137. SciVision Biotech Recent Development
    Table 138. Prollenium Company Detail
    Table 139. Prollenium Business Overview
    Table 140. Prollenium Injectable for Cosmetic Surgery Product
    Table 141. Prollenium Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 142. Prollenium Recent Development
    Table 143. Matex-Lab Company Detail
    Table 144. Matex-Lab Business Overview
    Table 145. Matex-Lab Injectable for Cosmetic Surgery Product
    Table 146. Matex-Lab Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 147. Matex-Lab Recent Development
    Table 148. Jingjia Medical Company Detail
    Table 149. Jingjia Medical Business Overview
    Table 150. Jingjia Medical Injectable for Cosmetic Surgery Product
    Table 151. Jingjia Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 152. Jingjia Medical Recent Development
    Table 153. Genoss Company Detail
    Table 154. Genoss Business Overview
    Table 155. Genoss Injectable for Cosmetic Surgery Product
    Table 156. Genoss Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 157. Genoss Recent Development
    Table 158. Bohus BioTech Company Detail
    Table 159. Bohus BioTech Business Overview
    Table 160. Bohus BioTech Injectable for Cosmetic Surgery Product
    Table 161. Bohus BioTech Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 162. Bohus BioTech Recent Development
    Table 163. Caregen Company Detail
    Table 164. Caregen Business Overview
    Table 165. Caregen Injectable for Cosmetic Surgery Product
    Table 166. Caregen Revenue in Injectable for Cosmetic Surgery Business (2019-2024) & (US$ Million)
    Table 167. Caregen Recent Development
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Injectable for Cosmetic Surgery Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Injectable for Cosmetic Surgery Market Share by Type: 2023 VS 2030
    Figure 3. Botulinum Toxin Features
    Figure 4. Soft Tissue Fillers Features
    Figure 5. Dermal Fillers Features
    Figure 6. Others Features
    Figure 7. Global Injectable for Cosmetic Surgery Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Injectable for Cosmetic Surgery Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Dermatology Clinics Case Studies
    Figure 11. Beauty Centers Case Studies
    Figure 12. Othes Case Studies
    Figure 13. Injectable for Cosmetic Surgery Report Years Considered
    Figure 14. Global Injectable for Cosmetic Surgery Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Injectable for Cosmetic Surgery Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Injectable for Cosmetic Surgery Market Share by Region: 2023 VS 2030
    Figure 17. Global Injectable for Cosmetic Surgery Market Share by Players in 2023
    Figure 18. Global Top Injectable for Cosmetic Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable for Cosmetic Surgery as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Injectable for Cosmetic Surgery Revenue in 2023
    Figure 20. North America Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Injectable for Cosmetic Surgery Market Share by Country (2019-2030)
    Figure 22. United States Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Injectable for Cosmetic Surgery Market Share by Country (2019-2030)
    Figure 26. Germany Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Injectable for Cosmetic Surgery Market Share by Region (2019-2030)
    Figure 34. China Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Injectable for Cosmetic Surgery Market Share by Country (2019-2030)
    Figure 42. Mexico Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Injectable for Cosmetic Surgery Market Share by Country (2019-2030)
    Figure 46. Turkey Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Injectable for Cosmetic Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. AbbVie Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 49. Galderma Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 50. LG Life Sciences Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 51. Merz Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 52. Medytox Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 53. HUGEL Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 54. Croma-Pharma Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 55. Beijing IMEIK Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 56. Bloomage Bio Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 57. Elravie (Humedix) Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 58. Cleviel (Pharma Research Products) Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 59. Haohai Biological Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 60. Q.O.Fill (JW Pharmaceutical) Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 61. Teoxane Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 62. Sinclair Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 63. Suneva Medical Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 64. CG Bio Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 65. SciVision Biotech Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 66. Prollenium Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 67. Matex-Lab Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 68. Jingjia Medical Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 69. Genoss Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 70. Bohus BioTech Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 71. Caregen Revenue Growth Rate in Injectable for Cosmetic Surgery Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS